EE04801B1 - Leptiin kui tuumorirakkude proliferatsiooni inhibiitor - Google Patents

Leptiin kui tuumorirakkude proliferatsiooni inhibiitor

Info

Publication number
EE04801B1
EE04801B1 EEP199900510A EEP9900510A EE04801B1 EE 04801 B1 EE04801 B1 EE 04801B1 EE P199900510 A EEP199900510 A EE P199900510A EE P9900510 A EEP9900510 A EE P9900510A EE 04801 B1 EE04801 B1 EE 04801B1
Authority
EE
Estonia
Prior art keywords
leptin
inhibitor
cell proliferation
tumor cell
tumor
Prior art date
Application number
EEP199900510A
Other languages
English (en)
Estonian (et)
Inventor
Barkan Dalit
Cohen Batya
Rubinstein Menachem
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of EE9900510A publication Critical patent/EE9900510A/xx
Publication of EE04801B1 publication Critical patent/EE04801B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2264Obesity-gene products, e.g. leptin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EEP199900510A 1997-04-29 1998-04-26 Leptiin kui tuumorirakkude proliferatsiooni inhibiitor EE04801B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL12073397A IL120733A0 (en) 1997-04-29 1997-04-29 Leptin as an inhibitor of cell proliferation
PCT/IL1998/000196 WO1998048831A1 (en) 1997-04-29 1998-04-26 Leptin as an inhibitor of tumor cell proliferation

Publications (2)

Publication Number Publication Date
EE9900510A EE9900510A (et) 2000-06-15
EE04801B1 true EE04801B1 (et) 2007-04-16

Family

ID=11070075

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900510A EE04801B1 (et) 1997-04-29 1998-04-26 Leptiin kui tuumorirakkude proliferatsiooni inhibiitor

Country Status (26)

Country Link
US (1) US7109159B1 (uk)
EP (1) EP0981365B1 (uk)
JP (1) JP4330662B2 (uk)
KR (1) KR100507731B1 (uk)
CN (1) CN1168497C (uk)
AR (1) AR012626A1 (uk)
AT (1) ATE283702T1 (uk)
AU (1) AU742927B2 (uk)
BG (1) BG63490B1 (uk)
CA (1) CA2288238A1 (uk)
CZ (1) CZ299872B6 (uk)
DE (1) DE69827942T2 (uk)
EA (1) EA002353B1 (uk)
EE (1) EE04801B1 (uk)
ES (1) ES2232944T3 (uk)
HK (1) HK1028350A1 (uk)
HU (1) HUP0002427A3 (uk)
IL (2) IL120733A0 (uk)
NO (1) NO322304B1 (uk)
NZ (1) NZ500589A (uk)
PL (1) PL195275B1 (uk)
PT (1) PT981365E (uk)
SK (1) SK284848B6 (uk)
UA (1) UA66793C2 (uk)
WO (1) WO1998048831A1 (uk)
ZA (1) ZA983608B (uk)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777388B1 (en) 1998-08-21 2004-08-17 Clf Medical Technology Acceleration Program, Inc. Leptin-related peptides
US7208572B2 (en) 1998-08-21 2007-04-24 Albany Medical College Leptin-related peptides
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
IL132312A0 (en) * 1999-09-05 2001-03-19 Yeda Res & Dev Use of leptin in inhibition of endothelial cell proliferation
BRPI0507594A (pt) 2004-02-11 2007-07-03 Amylin Pharmaceuticals Inc polipetìdeos hìbridos com propriedades selecionáveis
US8076288B2 (en) 2004-02-11 2011-12-13 Amylin Pharmaceuticals, Inc. Hybrid polypeptides having glucose lowering activity
US7863240B2 (en) * 2004-10-08 2011-01-04 Enzo Therapeutics, Inc. Methods and uses of leptin in hepatocellular carcinoma
US8969291B2 (en) 2004-10-08 2015-03-03 Enzo Therapeutics, Inc. Methods for decreasing leptin levels or activity for treating inflammation
BRPI0606992A2 (pt) 2005-02-11 2009-07-28 Amylin Pharmaceuticals Inc análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
BRPI0614649A2 (pt) 2005-08-11 2011-04-12 Amylin Pharmaceuticals Inc polipeptìdeos hìbridos com propriedades selecionáveis
EP2330124B1 (en) 2005-08-11 2015-02-25 Amylin Pharmaceuticals, LLC Hybrid polypeptides with selectable properties
US8227408B2 (en) * 2005-09-07 2012-07-24 Neurotez, Inc. Leptin as an anti-amyloidogenic biologic and methods for delaying the onset and reducing Alzheimer's disease-like pathology
US8497240B2 (en) 2006-08-17 2013-07-30 Amylin Pharmaceuticals, Llc DPP-IV resistant GIP hybrid polypeptides with selectable properties
CN103694337B (zh) 2008-02-08 2016-03-02 Ambrx公司 经修饰瘦素多肽和其用途
KR20110028457A (ko) * 2008-05-21 2011-03-18 뉴로테즈 인코포레이티드 신경섬유 매듭과 연관된 신경변성 장애를 치료하는 방법
CA2742600A1 (en) * 2008-11-04 2010-05-14 Nikolaos Tezapsidis Leptin compositions and methods for treating progressive cognitive function disorders resulting from accumulation of neurofibrillary tangles and amlyoid beta
WO2010146059A2 (en) 2009-06-16 2010-12-23 F. Hoffmann-La Roche Ag Biomarkers for igf-1r inhibitor therapy
TWI824372B (zh) 2015-10-12 2023-12-01 美商再生元醫藥公司 活化瘦素受體的抗原結合蛋白
CN110167965A (zh) 2016-11-08 2019-08-23 瑞泽恩制药公司 拮抗瘦素受体的抗原结合蛋白
US11834500B2 (en) 2017-12-18 2023-12-05 Regeneron Pharmaceuticals, Inc. Bispecific antigen binding molecules that bind leptin receptor and/or GP130, and methods of use thereof
KR20200141461A (ko) 2018-04-06 2020-12-18 리제너론 파마슈티칼스 인코포레이티드 렙틴 수용체 작용제 항체를 사용한 치료 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9802609A2 (hu) * 1995-06-30 1999-03-29 Eli Lilly And Co. A diabetes kezelésére szolgáló eljárás
EP0764722A2 (en) * 1995-09-19 1997-03-26 Eli Lilly And Company DNA encoding primate leptins as medicinal proteins
EP1731164A1 (en) * 1996-01-23 2006-12-13 Indevus Pharmaceuticals, Inc. Methods for using the obese gene and its gene product to stimulate hematopoietic development

Also Published As

Publication number Publication date
IL132633A (en) 2007-07-04
EA199900981A1 (ru) 2000-04-24
SK147199A3 (en) 2000-06-12
KR100507731B1 (ko) 2005-08-10
DE69827942D1 (de) 2005-01-05
ZA983608B (en) 1998-11-02
UA66793C2 (uk) 2004-06-15
IL120733A0 (en) 1997-08-14
NO995267D0 (no) 1999-10-28
PL336582A1 (en) 2000-07-03
EA002353B1 (ru) 2002-04-25
KR20010012080A (ko) 2001-02-15
NO322304B1 (no) 2006-09-11
CN1168497C (zh) 2004-09-29
AR012626A1 (es) 2000-11-08
NO995267L (no) 1999-12-28
DE69827942T2 (de) 2005-12-08
CN1261802A (zh) 2000-08-02
PT981365E (pt) 2005-03-31
NZ500589A (en) 2001-03-30
AU7076298A (en) 1998-11-24
SK284848B6 (sk) 2006-01-05
PL195275B1 (pl) 2007-08-31
ES2232944T3 (es) 2005-06-01
US7109159B1 (en) 2006-09-19
EP0981365A1 (en) 2000-03-01
ATE283702T1 (de) 2004-12-15
CZ384899A3 (cs) 2000-06-14
EP0981365B1 (en) 2004-12-01
JP2001524968A (ja) 2001-12-04
EE9900510A (et) 2000-06-15
JP4330662B2 (ja) 2009-09-16
CZ299872B6 (cs) 2008-12-17
HUP0002427A3 (en) 2003-02-28
BG103832A (en) 2000-10-31
HK1028350A1 (en) 2001-02-16
WO1998048831A1 (en) 1998-11-05
HUP0002427A2 (hu) 2000-12-28
CA2288238A1 (en) 1998-11-05
BG63490B1 (bg) 2002-03-29
AU742927B2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
EE04801B1 (et) Leptiin kui tuumorirakkude proliferatsiooni inhibiitor
EE200000706A (et) Bitsüklilised pürimidiinid ja bitsüklilised 3,4-dihüdropürimidiinid kui rakkude proliferatsiooni inhibiitorid
EE03685B1 (et) Asendatud benseensulfoonamiidi derivaadid kui COX-2 inhibiitorite eelravimid
DE69928195D1 (de) Komplettierung von Untrerdruck-Bohrlöchern
DE69716615D1 (de) Heterozyklische metalloproteaseinhibitoren
DE19882069T1 (de) Voraussage logarithmischer Reduktionswerte
DK0923585T3 (da) Phosphinatbaserede inhibitorer af matrixmetalloproteinaser
ID24612A (id) Hidrogenolisis gliserol
DK1027332T3 (da) Hidtil ukendte lactametalloproteaseinhibitorer
DK1181269T3 (da) Celleproliferationsinhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
DE69941468D1 (de) Zeitabgleichung von Aufwärtsverbindungs CDMA-Signalen
PT927183E (pt) Inibidores espirociclicos de metaloproteases
EE03871B1 (et) Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid
IT240802Y1 (it) Struttura di dischetto levatrucco
IL132633A0 (en) Leptin as an inhibitor of tumor cell proliferation
SI0981365T1 (en) Leptin as an inhibitor of tumor cell proliferation
ID17419A (id) Komposisi dekafluoropentana
DK0981365T3 (da) Leptin som en inhibitor af tumorcelleproliferation
FI102727B1 (fi) Henkilökohtainen maadoitus
KR980005037U (ko) 복사방지 테이프의 강제 복사 회로
KR960038383U (ko) 전원공급장치의 과전력 보호회로
KR970047227U (ko) 파워 안테나의 베이스
DE69942093D1 (de) Verwaltungsschema von Rundsendung
ID17459A (id) Unsur-unsur pengobatan

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20130426